Effect of switching administration of alendronate after teriparatide for the prevention of BMD loss around the implant after total hip arthroplasty, 2-year follow-up: a randomized controlled trial

Effect of switching administration of alendronate after teriparatide for the prevention of BMD loss around the implant after total hip arthroplasty, 2-year follow-up: a randomized controlled trial

Abstract Background Stress shielding after total hip arthroplasty (THA) can induce bone mineral density (BMD) loss around the femoral implant. Several studies using drug have described methods to prevent BMD loss around implants following THA. Switching from teriparatide to alendronate was reported...

Full description

Bibliographic Details
Main Authors: Akira Morita, Naomi Kobayashi, Hyonmin Choe, Hiroyuki Ike, Taro Tezuka, Shota Higashihira, Yutaka Inaba
Format: Article
Language:English
Published: BMC 2020-01-01
Series:Journal of Orthopaedic Surgery and Research
Subjects:
Bone mineral density (BMD)
Total hip arthroplasty (THA)
Teriparatide
Alendronate (ALD)
Online Access:https://doi.org/10.1186/s13018-020-1547-5

Internet

https://doi.org/10.1186/s13018-020-1547-5

Similar Items